News and blogs

Test and treat analysis from Eastern Uganda finds 90% of people diagnosed start treatment – but one in five has left care after 12 months

Government initiative increases retention in care by a third but struggles to expand treatment access or reduce deaths among people with HIV.

Gay men and transgender women who have sex with men in Nairobi and Johannesburg are active social media users, possibly providing an untapped opportunity for sexual health promotion on these platforms. 

User fees lead to a ‘drastic’ fall in the number of people starting HIV care at a PEPFAR-funded clinic in Lagos.

An HIV testing initiative that targeted male-dominated workplaces and social spaces, and notified the sexual partners of anyone testing positive, results in 25% of men being diagnosed with HIV

New Kenyan trial providing HIV self-tests to sex workers sees high levels of partner testing – and increased condom use when men refused to test

Dutch study finds no evidence to suggest PrEP use increases mental health issues – and may actually help reduce sexual compulsivity and drug-misuse.

Research suggests women with disabilities are significantly more vulnerable to HIV than other women and disabled men – and that this is linked to sexual violence.

Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.

Journalist Levy Ngosa explores how stigma & discrimination of the LGBT+ community in Zambia stops access to HIV prevention and treatment services

An SMS service co-created with sex workers to improve their sexual health met with keen approval during testing.

Around 70% of people aged 50-plus receiving HIV care in Latin America in 2015 had an NCD, compared to 32% in the year 2000.

The proportion of South Africans ever testing for HIV increased from 30% to 75% between 2005 and 2017 – but differences remain in who is getting tested

When starting treatment in the third trimester, women taking dolutegravir more likely to achieve undetectable viral loads at the time of giving birth compared with those taking efavirenz.

A pilot scheme that immediately rebooks and provides a reminder for an HIV retest six months later increases attendance by 25%.

People on integrase inhibitors found to gain more weight on average than those on other treatment regimens